NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

After completion of chemo-rad. About 4 months past diagnosis (median) IIRC.

But their trial numbers show OS from randomization., The argument here by longs is that NEBO should count OS from surgery and compare that to NVCR's post randomization numbers.

If it is right for NWBO to back up to surgery, why should NVCR not do so also? Hell, why not diagnosis? ATL claims it does not matter when you start counting, and dozens here agree.